• About Us
  • Who Are We
  • Work With Us
Sunday, January 29, 2023
No Result
View All Result
NEWSLETTER
The Globe Post
39 °f
New York
44 ° Fri
46 ° Sat
40 ° Sun
41 ° Mon
No Result
View All Result
The Globe Post
No Result
View All Result
Home National

New Data Released on Moderna Vaccine, Paving Way for Approval

Staff Writer by Staff Writer
12/15/20
in National
The rollout of six million doses of the Moderna vaccine could start soon.

The rollout of six million doses of the Moderna vaccine could start soon. Photo: Joel Saget/AFP via Getty

Share on FacebookShare on Twitter

The US regulator on Tuesday released new data confirming Moderna‘s Covid-19 vaccine was safe and effective, a strong sign that it could receive emergency approval in days and be ready to roll out by next week.

The Food and Drug Administration said there were “no specific safety concerns identified that would preclude issuance of an EUA (emergency use authorization)” and confirmed an overall efficacy of 94.1 percent.

Distribution of the Pfizer–BioNTech vaccine began on Monday and if the FDA green lights Moderna’s, rollout of some six million doses could start next Monday.

That would represent a powerful second weapon in the country with the world’s biggest outbreak of the virus, where more than 300,000 people have died and a winter surge is raging.

Also Tuesday, the FDA announced it had approved the first at-home rapid Covid-19 test, which will be available without prescription and return results in about 20 minutes.

But supply of the test, made by California-based Ellume, will initially be limited, with just three million units expected in January.

Stops severe cases

The FDA document on the Moderna vaccine offered the clearest look yet into the two-dose regimen, co-developed with the National Institutes of Health (NIH).

Moderna began working on the vaccine in January and has received $2.5 billion in federal funds.

On Thursday, an independent group of scientists will convene to debate everything known so far about the product. 

The panel is expected to vote in favor of an EUA, and the FDA normally heeds its recommendations.

According to the new data, the shots protected younger people slightly better than older people.

In a clinical trial of 30,400 people, 196 fell ill with Covid-19 by November 21 — 11 in the vaccine group and 185 in the placebo group.

Efficacy was 95.6 percent for people aged 18-65; 86.4 percent among those aged 65 and older; and 94.1 percent overall.

Importantly, of 30 cases of severe Covid-19, all occurred in the placebo group.

The FDA also looked at detailed safety data at a median of nine weeks after participants received the second shot, 28 days after the first.

Cutting-edge technology

The most common side effects associated with the drug, called mRNA-1273, were injection site pain in roughly 90 percent of cases; fatigue in 70 percent, headache in 60 percent, muscle pain in 60 percent, joint pain in 45 percent and chills in 45 percent.

Few of these effects were classed as “severe” and, when they were, that tended to occur more in the young than in the old. 

Lymphadenopathy, or swollen lymph nodes, occurred in 1.1 percent of the vaccine group against 0.6 percent of the placebo group.

There was an imbalance in allergic reactions, which occurred in 1.5 percent of the vaccinated population compared to 1.1 percent of the non-vaccinated.

But none were classed as severe or anaphylactic.

The frequency of life-threatening events was low, around one percent in each group, with no suggestion the vaccine was the cause.

To date, there have been three reports of Bell’s palsy — a facial paralysis condition, most often temporary — in the vaccine group and one in the placebo group.

The Pfizer trial saw four people get Bell’s palsy in the vaccine group, and none in the placebo group.

The FDA said there was insufficient information to determine that either vaccine was the cause.

Andrew Morris, a University of Toronto professor of medicine who has studied the condition, said “it is becoming increasingly likely that there is an important relationship with Bell’s (facial) palsy.”  

However, “the absolute risk — in light of the risks associated with Covid-19 — is small,” he stressed.

Both the Pfizer and Moderna vaccines use mRNA (messenger ribonucleic acid) molecules to cause human cells to express a surface molecule of the new coronavirus.

This simulates an infection and trains the immune system to be ready in case it encounters the real virus.

The mRNA is encased inside fatty particles. 

Both companies used a slightly different formulation resulting in different cold-storage requirements: -70 degrees Celsius (-94 degrees Fahrenheit) for Pfizer; -20 degrees Celsius (-4 Fahrenheit) for Moderna.

Moderna has applied for approval in over-18s, while Pfizer’s approval is for over-16s. 

ShareTweet
Staff Writer

Staff Writer

AFP with The Globe Post

Related Posts

Pfizer logo and vaccines
World

Pfizer to Sell More Drugs at Cost to Poor Nations

by Staff Writer
January 18, 2023
A woman undergoing COVID test in China
Featured

Soaring Covid Cases Shine Light on China’s Healthcare Gap

by Staff Writer
January 11, 2023
European Medicines Agency
World

EU Watchdog Approves Second Covid Booster for Over 80s

by Staff Writer
April 6, 2022
WHO
World

WHO Urges Rich Countries to Pay Up for Covid Plan

by Staff Writer
February 9, 2022
Mask making
National

US Sets Global Record of Over 1 Mn Daily Covid-19 Cases

by Staff Writer
January 4, 2022
Israel Covid vaccine
World

Israel ‘Leads the Way’ With 4th Covid Jabs for Vulnerable

by Staff Writer
December 31, 2021
Next Post
Playing the Un-Naming Game in New York Is Harder Than It Seems

Pandenomics: The High Cost of Living While Undocumented in the United States

Conversion therapy has affected hundreds of thousands of individuals in the US.

More Than 300 Religious Leaders Urge Ban on 'Conversion Therapy'

Recommended

The Doomsday Clock reads 100 seconds to midnight, a decision made by The Bulletin of Atomic Scientists, during an announcement at the National Press Club in Washington, DC on January 23, 2020

‘Doomsday Clock’ Moves Closest Ever to Midnight

January 25, 2023
Police work near the scene of a mass shooting in Monterey Park, California

California Lunar New Year Mass Shooter Dead, Motive Unclear: Police

January 23, 2023
New Zealand Prime Minister Jacinda Ardern

Race on To Replace Ardern as New Zealand Prime Minister

January 20, 2023
Pfizer logo and vaccines

Pfizer to Sell More Drugs at Cost to Poor Nations

January 18, 2023
Rescuers inspect the wreckage at the site of a Yeti Airlines plane crash in Pokhara, Nepal

At Least 67 Killed in Nepal Plane Crash

January 16, 2023
George Santos from the 3rd Congressional district of New York

George Santos for Speaker!

January 16, 2023

Opinion

George Santos from the 3rd Congressional district of New York

George Santos for Speaker!

January 16, 2023
Commuters waiting for buses in Metro Manila. Philippines

Eight Billion and Counting…

November 29, 2022
Mahsa Amini protests

Imagining a Free Iran

October 24, 2022
Vladimir Putin

How 18th Century International Law Clarifies the Situation in Ukraine

September 29, 2022
Vladimir Putin

Falling for Putin

September 15, 2022
US President Donald Trump

Donald Trump Thanks You for Your Sacrifice

August 17, 2022
Facebook Twitter

Newsletter

Do you like our reporting?
SUBSCRIBE

About Us

The Globe Post

The Globe Post is part of Globe Post Media, a U.S. digital news organization that is publishing the world's best targeted news sites.

submit oped

© 2018 The Globe Post

No Result
View All Result
  • National
  • World
  • Business
  • Interviews
  • Lifestyle
  • Democracy at Risk
    • Media Freedom
  • Opinion
    • Editorials
    • Columns
    • Book Reviews
    • Stage
  • Submit Op-ed

© 2018 The Globe Post